Albany NY, United States: Jet injector device is a medical device that uses a needle-free injection system.
Albany NY, United States: Jet injector device is a medical device that uses a needle-free injection system. The injector delivers drugs, vaccines, compounds, anesthetics, steroids, or insulin in a very fine stream of fluid by high-pressure precision. The high pressure is produced either by using nitrogen-filled or carbon-dioxide-filled cartridge or a spring. The medication is forced through a tiny opening in the device, which allows the drug to penetrate the skin and is administered into the underlying tissue either intramuscularly, subcutaneously, or intradermal.
Read Report Overview - https://www.transparencymarketresearch.com/jet-injector-device-market.html
The jet injector device provides (with minimal training) reproducible, reliable, and accurate delivery of medication, eliminates the need for “sharps” disposal, reduces risks such as cross-contamination and needle stick injuries, enhances compliance, and is less painful for the patient. These attributes are expected to drive the global jet injector device market. Increased inclination toward minimal invasive methods can further boost the demand for jet injectors. Improved patient convenience due to ease in professional and self-medication uses can drive the growth of the market during the forecast period. According to the International Diabetes Federation, the rate of diagnosis of diabetes has increased from 30 million people to 246 million people in India, China, and the U.S., over the last decades. Increasing incidence of diabetes drives the jet injector devices market. However, some formulations of vaccines and medications produce a stinging or burning sensation, whether it is administered using a jet injector or a needle.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30641
The global jet injector device market can be segmented based onproduct type, methods of injection, end-user, medication type, and region. In terms of product type, the market can be classified into powder jet injections, liquid jet injections, and depot or projectile jet injections. Based on the methods of injection, the market can be classified into gas powdered jet injector, spring load jet injector, and battery powdered jet injector. In terms of end-user, the market can be categorized into podiatric clinics, dental clinics, veterinary clinics, ambulatory surgical centers, and hospitals. In terms of the medication type, the global jet injector device market can be divided into vaccines, drugs, aesthetics, hormones, genes, and others.
Request for Analysis of COVID-19 Impact on Jet Injector Device Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30641
Geographically, the global jet injector device market can be classified into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant market share in the year 2016, owing to technological advancements in research & development, high awareness, and early adoption of jet injector devices. Europe held the second largest market share in 2016 due to government initiatives to promote good health in the region. Asia Pacific market is expected to expand during the forecast period. The growth can be accredited to increasing life expectancy in the region. According to World Health Organization (WHO), life expectancy continues to rise in the South East Asia region. Since 2000, life expectancy has increased at nearly 3.5 years per decade. The life expectancy in the region was 69.0 in 2015. The global jet injector device market in Africa is anticipated to grow during the forecast period owing to the increasing prevalence of diabetes. According to WHO, by 2030, the estimated number of diabetes cases will reach nearly 23.9 million in Africa. In surveys carried out by WHO, approximately 15% of adults between the ages of 25 and64 suffer from diabetes.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=30641
Key players of the global jet injector device market are PharmaJet, MK Global Co., Spirit Healthcare Ltd, Valeritas, Inc, Lundbeck Limited, Crossject needle-free injection systems, InjexUK, and Antares Pharma.
Pre Book Jet Injector Device Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=30641<ype=S
This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.
More Trending Reports by Transparency Market Research:
Oncology Information System Market The drive for oncology information systems (OIS) in cancer management is gathering strength from the need for coordinating care among providers. Broadly, such systems integrate vendor offerings with disparate healthcare information technology (HIT) systems. A multidisciplinary approach is necessary for patient-centered care in oncology, which makes the integration imperative for advancing workflows and usability.
Gold Nanoparticles Market Advancements in the field of nanotechnology and soaring need for metal nanoparticles across various end-use industries are likely to significantly rub off on demand for gold nanoparticles. Adoption of gold nanoparticles has been witnessing a considerable rise for nano-technology based diagnostics and therapeutics in the medical field. They seek extensive adoption for applications including treatment of tumor and cancer, along with targeted diagnosis in patients.
Respiratory Syncytial Virus Therapeutics Market Respiratory syncytial virus (RSV) is a common and contagious virus that infects the respiratory tract of children and adults. A RSV infection can lead to serious problems such as bronchiolitis and pneumonia. In terms of revenue, the global respiratory syncytial virus (RSV) therapeutics market was valued at US$ 841.4 Mn in 2016 and is anticipated to reach more than US$ 2100.0 Mn by 2025, expanding at a CAGR of 11.7% from 2017 to 2025.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453